Core Viewpoint - The company, Tianyu Biotechnology Co., Ltd., has released its quarterly report, ensuring the accuracy and completeness of the financial information presented, and confirming that there are no false records or significant omissions [2][3]. Financial Data Summary - The financial statements for the first quarter of 2025 are unaudited, with the company reporting a net profit of 0 yuan for the merged entity, both for the current and previous periods [3][6]. - The company has not applied new accounting standards or interpretations that would affect the financial statements for the year [6]. Shareholder Information - The total number of ordinary shareholders and the status of shares held by the top ten shareholders are disclosed, with specific shares being judicially frozen due to legal disputes involving major shareholders [4][5].
天域生物科技股份有限公司 2025年第一季度报告